- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02.07. | 53 biotech leaders urge FDA not to restrict mifepristone access over 'fatally flawed' report | ||
| 02.07. | Peter Pitts talks FDA outlook and industry's role | ||
| 02.07. | China approves 4 new drugs, including a global first-in-class medicine | ||
| 02.07. | AstraZeneca's Soriot is considering move of stock listing to the US: Times | ||
| 02.07. | Regulatory tracker: Merck nabs FDA priority review in bid to soup up Winrevair's label | ||
| 02.07. | Boehringer backs education drive to improve bronchiectasis management | ||
| 02.07. | Why 'emboldened' activist investors are taking the fight to biotechs | ||
| 02.07. | Regulatory tracker: Sobi's Gamifant gains new FDA approval in Still's disease | ||
| 01.07. | Bausch + Lomb builds out dry eye awareness push with new survey, patient stories | ||
| 01.07. | RFK Jr. brings in team to 'revolutionize' US vaccine injury compensation program | ||
| 01.07. | Torrent Pharma shells out $1.4B to take over controlling stake in India's JB Pharma from KKR | ||
| 01.07. | Sobi agrees to pay up to $300M to reduce royalty payments to Apellis on Empaveli | ||
| 01.07. | FDA weighs regulatory action on argenx's Vyvgart Hytrulo amid reports of 'severe worsening' of disease | ||
| 01.07. | EuroAPI sheds UK facility as restructuring plan rolls on | ||
| 01.07. | Power couple Peetes team up to promote Sumitomo's Gemtesa | ||
| 01.07. | Amid pricing squeeze and market withdrawals, Europe must prioritize generic manufacturing, Teva exec says | ||
| 30.06. | ADA: From boy band star to Dexcom diabetes Warrior, Lance Bass talks his CGM treatment journey | ||
| 30.06. | Takeda survey finds colon cancer patients feel unheard by HCPs, want more info on diagnosis, treatment | ||
| 30.06. | FDA hits Unicycive with manufacturing-related complete response letter, delaying hopes for kidney disease prospect | ||
| 30.06. | Sage lays off entire staff of 338 amid takeover by Supernus | ||
| 30.06. | Orphan Cures Act re-added to Trump tax bill as Senate prepares to begin vote-a-rama | ||
| 30.06. | Sandoz recalls one lot of antibacterial drug cefazolin due to mispackaging | ||
| 30.06. | Hikma to splash $1B on US production and R&D, joining branded drugmakers' investment spree | ||
| 27.06. | UCB plots regulatory filings as Fintepla shows potential to treat a 3rd epilepsy disorder | ||
| 27.06. | Sophia Genetics launches podcast to decode data- and AI-driven medical innovation |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .